Atlas Trials

The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma

Clinical trial NCT02700464 · COMPLETED

Trial details

NCT number
NCT02700464
Sponsor
Nucleix Ltd.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2016-09-01
Primary completion
2020-04-01
Enrollment
680

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.